Literature DB >> 8564113

IgG subclass deficiencies associated with bronchiectasis.

J De Gracia1, M J Rodrigo, F Morell, M Vendrell, M Miravitlles, M J Cruz, R Codina, J M Bofill.   

Abstract

Only a small number of patients with IgG subclass deficiencies (IgGSD) have been observed to have bronchiectasis. Moreover, in the series of patients with bronchiectasis, IgGSD have not been found at any frequency, and the etiology of bronchiectasis remains unclear in 29 to 49% of cases. Serum concentrations of total IgG, IgA, and IgG subclasses as well as pulmonary function were measured in 65 patients (aged: 10 to 74 yr) with bronchiectasis of unknown etiology. An ELISA test was performed to quantify subclasses 1 through 4 using subclass-specific antihuman monoclonal antibodies. IgG subclass estimation in a healthy population with age-stratified normal ranges was derived from 100 adults, 37 children aged between 10 and 12 yr, and 27 adolescents aged between 13 and 16 yr. Serum concentrations of specific IgG antibodies to Haemophilus influenzae type b capsular polysaccharide (Hib-PRP) were also assayed by an ELISA test in 19 of the patients (10 with IgGSD and nine with non-IgGSD) and in 58 healthy individuals before and 3 wk after immunization with Hib-PRP conjugated to meningococcal outer membrane protein complex (OMPC). Thirty-one patients (48%) had low serum concentrations of one or more IgG subclasses (19 IgG2 deficiencies, 2 IgG3 deficiencies, 3 IgG4 deficiencies, and 7 combined subclass deficiencies). All patients showed increased levels of total IgG, IgG1, and IgA, but this rise was significantly higher in patients without IgGSD. Patients with IgGSD showed impaired antibody response to Hib-PRP compared with patients with non-IgGSD and the control group. IgGSD, particularly IgG2 deficiency, are not an unusual cause of bronchiectasis. Therefore, serum levels of IgG subclasses must be assayed whenever other causes of bronchiectasis have been ruled out.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564113     DOI: 10.1164/ajrccm.153.2.8564113

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

1.  IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations.

Authors:  I Qvarfordt; G C Riise; B A Andersson; S Larsson
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

2.  Assessing immune function in adult bronchiectasis.

Authors:  P T King; P Hutchinson; P W Holmes; N J Freezer; V Bennett-Wood; R Robins-Browne; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

Review 3.  A review of non-cystic fibrosis pediatric bronchiectasis.

Authors:  Eric J Boren; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

4.  Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.

Authors:  Uwe Schauer; Frank Stemberg; Christian H L Rieger; Wolfgang Büttner; Michael Borte; Simone Schubert; Helga Möllers; Frank Riedel; Udo Herz; Harald Renz; Wilhelm Herzog
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

5.  Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria.

Authors:  M J Rodrigo; M Miravitlles; M J Cruz; J de Gracia; M Vendrell; C Pascual; F Morell
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

Review 6.  Lung Disease in Primary Antibody Deficiencies.

Authors:  Edith Schussler; Mary B Beasley; Paul J Maglione
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

7.  IgG subclasses in the serum and sputum from patients with bronchiectasis.

Authors:  S L Hill; J L Mitchell; D Burnett; R A Stockley
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

8.  Humoral immunity and bronchiectasis.

Authors:  A Stead; J G Douglas; C J Broadfoot; E R Kaminski; R Herriot
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

Review 9.  Chronic Lung Disease in Primary Antibody Deficiency: Diagnosis and Management.

Authors:  Paul J Maglione
Journal:  Immunol Allergy Clin North Am       Date:  2020-06-09       Impact factor: 3.479

10.  Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum.

Authors:  Junghee J Shin; Daniel Liauw; Sabrina Siddiqui; Juhyeon Lee; Eun Jae Chung; Ryan Steele; Florence Ida Hsu; Christina Price; Insoo Kang
Journal:  J Clin Immunol       Date:  2020-04-02       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.